Premium
Mirum Pharmaceuticals Inc (MIRM)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, LP | Institution | 7 679 684 | 12,59% | US$ 710,29M | 2026-03-31 |
| Janus Henderson Group plc | Institution | 6 945 813 | 11,39% | US$ 642,42M | 2026-03-31 |
| BlackRock, Inc. | Institution | 3 846 406 | 6,31% | US$ 355,75M | 2026-03-31 |
| Frazier Life Sciences IX, L.P. | Institution | 3 566 912 | 5,85% | US$ 329,90M | 2026-01-23 |
| Frazier Life Sciences Public Fund, L.P. | Institution | 2 514 947 | 4,12% | US$ 232,61M | 2026-01-23 |
| Vanguard Capital Management, LLC | Institution | 2 414 776 | 3,96% | US$ 223,34M | 2026-03-31 |
| FMR LLC | Institution | 1 964 807 | 3,22% | US$ 181,72M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 1 944 281 | 3,19% | US$ 179,83M | 2026-03-31 |
| T. Rowe Price Group, Inc. | Institution | 1 717 421 | 2,82% | US$ 158,84M | 2026-03-31 |
| BVF Partners L.P. | Institution | 1 584 727 | 2,60% | US$ 146,57M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 1 432 083 | 2,35% | US$ 132,45M | 2026-03-31 |
| Eventide Asset Management, LLC | Institution | 1 408 871 | 2,31% | US$ 130,31M | 2026-03-31 |
| Wellington Management Group LLP | Institution | 1 334 809 | 2,19% | US$ 123,46M | 2026-03-31 |
| Novo Holdings A/S | Institution | 1 325 000 | 2,17% | US$ 122,55M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 1 260 003 | 2,07% | US$ 116,54M | 2026-03-31 |
| Tang Capital Management, LLC | Institution | 1 236 027 | 2,03% | US$ 114,32M | 2026-03-31 |
| TCG Crossover Management, LLC | Institution | 1 062 049 | 1,74% | US$ 98,23M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 1 052 048 | 1,73% | US$ 97,30M | 2026-03-31 |
| BNP Paribas Financial Markets SNC | Institution | 911 419 | 1,49% | US$ 84,30M | 2026-03-31 |
| Rock Springs Capital Management LP | Institution | 811 294 | 1,33% | US$ 75,04M | 2026-03-31 |
| Two Sigma Investments, LP | Institution | 774 841 | 1,27% | US$ 71,67M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 772 595 | 1,27% | US$ 71,46M | 2025-09-30 |
| Capital Research and Management Company | Institution | 724 415 | 1,19% | US$ 67,00M | 2026-03-31 |
| Franklin Resources, Inc. | Institution | 710 938 | 1,17% | US$ 65,75M | 2026-03-31 |
| Bank of America Corporation | Institution | 676 624 | 1,11% | US$ 62,58M | 2026-03-31 |
| ClearBridge Investments, LLC | Institution | 671 870 | 1,10% | US$ 62,14M | 2026-03-31 |
| Emerald Advisers, LLC | Institution | 647 662 | 1,06% | US$ 59,90M | 2026-03-31 |
| Paradigm Biocapital Advisors LP | Institution | 625 000 | 1,02% | US$ 57,81M | 2026-03-31 |
| Lord, Abbett & Co. LLC | Institution | 617 064 | 1,01% | US$ 57,07M | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 610 666 | 1,00% | US$ 56,48M | 2025-09-30 |
| Renaissance Technologies LLC | Institution | 582 085 | 0,95% | US$ 53,84M | 2026-03-31 |
| BNY Asset Management | Institution | 579 179 | 0,95% | US$ 53,57M | 2026-03-31 |
| Woodline Partners LP | Institution | 567 894 | 0,93% | US$ 52,52M | 2026-03-31 |
| UBS Asset Management AG | Institution | 561 623 | 0,92% | US$ 51,94M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 547 306 | 0,90% | US$ 50,62M | 2026-03-31 |
| Frazier Life Sciences XI, L.P. | Institution | 544 954 | 0,89% | US$ 50,40M | 2026-01-23 |
| Balyasny Asset Management L.P. | Institution | 539 031 | 0,88% | US$ 49,85M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
